Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-022955
Filing Date
2024-06-06
Accepted
2024-06-06 17:01:12
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1085349
2 ex31-1.htm EX-31.1 13189
3 ex31-2.htm EX-31.2 13542
4 ex32-1.htm EX-32.1 7117
5 ex32-2.htm EX-32.2 7866
  Complete submission text file 0001493152-24-022955.txt   6353110

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vhaq-20230331.xsd EX-101.SCH 39694
7 XBRL CALCULATION FILE vhaq-20230331_cal.xml EX-101.CAL 44055
8 XBRL DEFINITION FILE vhaq-20230331_def.xml EX-101.DEF 261910
9 XBRL LABEL FILE vhaq-20230331_lab.xml EX-101.LAB 338968
10 XBRL PRESENTATION FILE vhaq-20230331_pre.xml EX-101.PRE 302050
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 941107
Mailing Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326
Business Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39827 | Film No.: 241026282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)